🇦🇺 Australia Country × Condition
acute myeloid leukemia Clinical Trials in Australia
Active clinical trials for acute myeloid leukemia with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 3 // Recruiting: 3 Phases: Phase 3, Phase 2 // Updated: Daily
Total Trials
3
Recruiting Now
3
Country
🇦🇺 Australia
Active Trials in Australia (3)
NCT04293562 Phase 3
Recruiting
A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations
Enrollment
1,186 pts
Country
🇦🇺 Australia
Children's Oncology Group
View Trial → NCT06824168 Phase 2
Recruiting
Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission
Enrollment
130 pts
Country
🇦🇺 Australia
Daiichi Sankyo
View Trial → NCT04811560 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Enrollment
400 pts
Country
🇦🇺 Australia
Janssen Research & Development, LLC
View Trial → Frequently Asked Questions
How many acute myeloid leukemia clinical trials are active in Australia?
There are currently 3 active clinical trials for acute myeloid leukemia with sites in Australia, of which 3 are actively recruiting patients.
How can I join a acute myeloid leukemia clinical trial in Australia?
To join a acute myeloid leukemia clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are acute myeloid leukemia trials in Australia?
Active acute myeloid leukemia trials in Australia span Phase 3, Phase 2, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.